Literature DB >> 17551303

Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.

Min Yao1, Pifu Luo, Henry T Hoffman, Kristi Chang, Michael M Graham, Yusuf Menda, Huaming Tan, John M Buatti.   

Abstract

BACKGROUND: This study determines if postradiotherapy [18F]fluorodeoxyglucose positron emission tomography (FDG PET) can predict the pathology status of residual cervical lymph nodes in patients undergoing definitive radiotherapy for head and neck squamous cell carcinoma (HNSCC).
METHODS: Patients with stage N2 or higher HNSCC underwent PET and CT imaging after definitive radiotherapy. Patients with radiographically persistent lymphadenopathy underwent either neck dissection or fine needle aspiration (FNA) of the lymph nodes under ultrasound guidance. PET scan results were correlated with the pathologic findings of the residual lymphadenopathy.
RESULTS: Twenty-four hemi-necks in 23 patients with residual lymphadenopathy had neck dissection or FNA. The pathology correlated strongly with the post-RT FDG PET studies. All patients with a negative post-RT FDG PET and those with a maximum standardized uptake value (SUVmax) of less than 3.0 in the post-RT FDG PET were found to be free from residual viable tumor. Using a SUVmax of less than 3.0 as the criterion for a negative FDG PET study, the sensitivity, specificity, positive predictive value, and negative predictive value were 100%, 84.2%, 62.5%, and 100%, respectively.
CONCLUSIONS: A negative post-RT FDG PET is very predictive of negative pathology in the residual lymph node after definitive radiotherapy for advanced HNSCC. A prospective clinical trial is warranted to determine if neck dissection can be withheld in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551303     DOI: 10.1097/01.coc.0000257611.65290.aa

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  16 in total

1.  Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer.

Authors:  S S Yom; A S Garden; G A Staerkel; L E Ginsberg; W H Morrison; E M Sturgis; D I Rosenthal; J N Myers; B S Edeiken-Monroe
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

2.  Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.

Authors:  Tejpal Gupta; Zubin Master; Sadhana Kannan; Jai Prakash Agarwal; Sarbani Ghsoh-Laskar; Venkatesh Rangarajan; Vedang Murthy; Ashwini Budrukkar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-19       Impact factor: 9.236

3.  Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.

Authors:  Anuj Goenka; Luc G T Morris; Shyam S Rao; Suzanne L Wolden; Richard J Wong; Dennis H Kraus; Nisha Ohri; Jeremy Setton; Benjamin H Lok; Nadeem Riaz; Borys R Mychalczak; Heiko Schoder; Ian Ganly; Jatin P Shah; David G Pfister; Michael J Zelefsky; Nancy Y Lee
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

4.  Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

Authors:  Thomas J Galloway; Qiang Ed Zhang; Phuc Felix Nguyen-Tan; David I Rosenthal; Denis Soulieres; André Fortin; Craig L Silverman; Megan E Daly; John A Ridge; J Alexander Hammond; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-05-28       Impact factor: 7.038

5.  Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Authors:  Carryn M Anderson; Tangel Chang; Michael M Graham; Michael D Marquardt; Anna Button; Brian J Smith; Yusuf Menda; Wenqing Sun; Nitin A Pagedar; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

Review 6.  Efficacy of neck dissection in the management of isolated nodal recurrence after head and neck cancer treatment.

Authors:  Jimmy Yu-wai Chan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

7.  Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma.

Authors:  Hidenori Inohara; Keisuke Enomoto; Yoichiro Tomiyama; Ichiro Higuchi; Takehiro Inoue; Jun Hatazawa
Journal:  Mol Imaging Biol       Date:  2009-05-07       Impact factor: 3.488

8.  Effect of postradiotherapy neck dissection on nonregional disease sites.

Authors:  Mark C Ranck; Rainier Abundo; Gina Jefferson; Antonia Kolokythas; Barry L Wenig; Ralph R Weichselbaum; Michael T Spiotto
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-01       Impact factor: 6.223

9.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

10.  Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

Authors:  Benjamin J Moeller; Vishal Rana; Blake A Cannon; Michelle D Williams; Erich M Sturgis; Lawrence E Ginsberg; Homer A Macapinlac; J Jack Lee; K Kian Ang; K S Clifford Chao; Gregory M Chronowski; Steven J Frank; William H Morrison; David I Rosenthal; Randal S Weber; Adam S Garden; Scott M Lippman; David L Schwartz
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.